Readers!
 

Please consider donating to Behind the Black, by giving either a one-time contribution or a regular subscription, as outlined in the tip jar below. Your support will allow me to continue covering science and culture as I have for the past twenty years, independent and free from any outside influence.


 

Regular readers can support Behind The Black with a contribution via paypal:
 


 

Or with a subscription with regular donations from your Paypal or credit card account:


 

If Paypal doesn't work for you, you can support Behind The Black directly by sending your donation by check, payable to Robert Zimmerman, to
 

Behind The Black
c/o Robert Zimmerman
P.O.Box 1262
Cortaro, AZ 85652


New Ebola vaccine 100% successful in trial

Using a different experimental approach aimed not only to test a new vaccine but also to stem an Ebola outbreak, scientists have found the new vaccine is 100% successful in providing exposed individuals protection from the virus.

Rather than create a complicated time-consuming trial with a control group getting a placebo — which also allows the epidemic to rage undisturbed — they focused on a different approach:

The Guinea trial — called ‘Ebola, ça suffit’ in French (‘Ebola, that’s enough’) — tested a ring vaccination design, a strategy that was borrowed from successful smallpox eradication efforts in the 1970s. After one patient contracts the disease, their close contacts are vaccinated in the hope of stemming the onward spread of the virus.

The Guinea trial included two arms: one in which adults who had been in contact with someone infected with Ebola and their subsequent contacts were vaccinated shortly after the original patient developed Ebola, and a second in which contacts instead received the vaccine three weeks later. The trial tested a vaccine called rVSV-ZEBOV, which is composed of an attenuated livestock virus engineered to produce an Ebola protein. The vaccine was developed by the Public Health Agency of Canada and then licensed to the drug companies NewLink Genetics and Merck.

Of the 2,014 people who received the vaccine immediately as part of the first arm, none developed Ebola ten days after getting the vaccine. The 10-day window allows the vaccine to summon an immune response and accounts for any pre-existing Ebola infection. (A few people in the immediate vaccination group, however, did develop the disease between 1 and 10 days after vaccination.) That compares with 16 infections among the 2,380 people in the second arm.

The findings mean that the vaccine provided 100% protection from the virus.

The results bring hope that Ebola is now a defeated virus.

Pioneer cover

From the press release: From the moment he is handed a possibility of making the first alien contact, Saunders Maxwell decides he will do it, even if doing so takes him through hell and back.

 
Unfortunately, that is exactly where that journey takes him.

The vision that Zimmerman paints of vibrant human colonies on the Moon, Mars, the asteroids, and beyond, indomitably fighting the harsh lifeless environment of space to build new societies, captures perfectly the emerging space race we see today.

He also captures in Pioneer the heart of the human spirit, willing to push forward no matter the odds, no matter the cost. It is that spirit that will make the exploration of the heavens possible, forever, into the never-ending future.

Available everywhere for $3.99 (before discount) at amazon, Barnes & Noble, all ebook vendors, or direct from the ebook publisher, ebookit. And if you buy it from ebookit you don't support the big tech companies and I get a bigger cut much sooner.

Readers: the rules for commenting!

 

No registration is required. I welcome all opinions, even those that strongly criticize my commentary.

 

However, name-calling and obscenities will not be tolerated. First time offenders who are new to the site will be warned. Second time offenders or first time offenders who have been here awhile will be suspended for a week. After that, I will ban you. Period.

 

Note also that first time commenters as well as any comment with more than one link will be placed in moderation for my approval. Be patient, I will get to it.

Leave a Reply

Your email address will not be published. Required fields are marked *